Intravenous N-Acetylcysteine

Abstract

Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation (DUE) is also provided each month. With a subscription, the monographs are sent to you in print and CD ROM forms and are available online. Monographs can be customized to meet the needs of your facility. Subscribers to the The Formulary Monograph Service also receive access to a pharmacy bulletin board, The Formulary Information Exchange (The F.I.X.). All topics pertinent to clinical and hospital pharmacy are discussed on The F.I.X.

Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. If you would like information about The Formulary Monograph Service or The F.I.X., call The Formulary at 800-322-4349. The May 2004 monograph topics are cinacalcet hydrochloride, bevacizumab, mycophenolic acid delayed-release tablets, oblimersen sodium, and ciclesonide. The DUE is on cinacalcet hydrochloride.

Get full access to this article

View all access options for this article.

References

Intravenous N-acetylcysteine [prescribing information]. Cumberland Pharmaceuticals Inc.; February 2004.

Perry

H.E.

, Shannon

M.W.

Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: Results of an open-label, clinical trial.

J Pediatr. 1998; 132: 149–52.

Buckley

N.A.

Oral or intravenous N-acetylcysteine: Which is the treatment of choice for acetaminophen (paracetamol) poisoning?

Clin Toxicol. 1999; 37: 759–67.

Yip

Intravenous administration of oral N-acetylcysteine.

Crit Care Med. 1998; 26: 40–3.

Dargan

P.I.

, Jones

A.L.

Management of paracetamol poisoning.

Trends Pharmacol Sci. 2003; 24(4): 154–7.

Sheen

C.L.

Paracetamol toxicity: Epidemiology, prevention and costs to the health-care system.

QJ Med. 2002; 95: 609–19.

Kao

L.W.

What is the rate of adverse events after oral N-acetylcysteine administered by intravenous route to patients with suspected acetaminophen poisoning?

Ann Emerg Med. 2003; 42(6): 741–50.

Kiykim

Successful treatment of acute hepatic injury caused by paracetamol intoxication in a late-referral patient by N-acetylcysteine [letter].

J Clin Gastroenterol. 2003; 36: 372–3.

Amirzadeh

, McCotter

The intravenous use of oral acetylcysteine (Mucomyst) for the treatment of acetaminophen overdose [letter].

Arch Intern Med. 2002; 162: 96–7.

10.

Bailey

, McGuigan

M.A.

Management of anaphylactoid reactions to intravenous N-acetylcysteine.

Ann Emergency Med. 1998; 31: 710–5.